433 related articles for article (PubMed ID: 12620073)
1. 4-Hydroxymethyl-3-aminoacridine derivatives as a new family of anticancer agents.
Charmantray F; Demeunynck M; Carrez D; Croisy A; Lansiaux A; Bailly C; Colson P
J Med Chem; 2003 Mar; 46(6):967-77. PubMed ID: 12620073
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and biological properties of new bis(acridine-4-carboxamides) as anticancer agents.
Antonini I; Polucci P; Magnano A; Gatto B; Palumbo M; Menta E; Pescalli N; Martelli S
J Med Chem; 2003 Jul; 46(14):3109-15. PubMed ID: 12825949
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationships for substituted bis(acridine-4-carboxamides): a new class of anticancer agents.
Gamage SA; Spicer JA; Atwell GJ; Finlay GJ; Baguley BC; Denny WA
J Med Chem; 1999 Jul; 42(13):2383-93. PubMed ID: 10395479
[TBL] [Abstract][Full Text] [Related]
4. Potent antitumor 9-anilinoacridines and acridines bearing an alkylating N-mustard residue on the acridine chromophore: synthesis and biological activity.
Su TL; Lin YW; Chou TC; Zhang X; Bacherikov VA; Chen CH; Liu LF; Tsai TJ
J Med Chem; 2006 Jun; 49(12):3710-8. PubMed ID: 16759114
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of mono- and bisdihydrodipyridopyrazines and assessment of their DNA binding and cytotoxic properties.
Blanchard S; Rodriguez I; Tardy C; Baldeyrou B; Bailly C; Colson P; Houssier C; Léonce S; Kraus-Berthier L; Pfeiffer B; Renard P; Pierré A; Caubère P; Guillaumet G
J Med Chem; 2004 Feb; 47(4):978-87. PubMed ID: 14761199
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationships for acridine-substituted analogues of the mixed topoisomerase I/II inhibitor N-[2-(dimethylamino)ethyl]acridine-4-carboxamide.
Spicer JA; Gamage SA; Atwell GJ; Finlay GJ; Baguley BC; Denny WA
J Med Chem; 1997 Jun; 40(12):1919-29. PubMed ID: 9191970
[TBL] [Abstract][Full Text] [Related]
7. Antitumor agents. 3. Design, synthesis, and biological evaluation of new pyridoisoquinolindione and dihydrothienoquinolindione derivatives with potent cytotoxic activity.
Bolognese A; Correale G; Manfra M; Lavecchia A; Mazzoni O; Novellino E; La Colla P; Sanna G; Loddo R
J Med Chem; 2004 Feb; 47(4):849-58. PubMed ID: 14761187
[TBL] [Abstract][Full Text] [Related]
8. 5,7-Disubstituted analogues of the mixed topoisomerase I/II poison N-[2-(dimethylamino)ethyl]acridine-4-carboxamide (DACA): DNA binding and patterns of cytotoxicity.
Spicer JA; Finlay GJ; Baguley BC; Velea L; Graves DE; Denny WA
Anticancer Drug Des; 1999 Feb; 14(1):37-45. PubMed ID: 10363026
[TBL] [Abstract][Full Text] [Related]
9. Rational design, synthesis, and biological evaluation of bis(pyrimido[5,6,1-de]acridines) and bis(pyrazolo[3,4,5-kl]acridine-5-carboxamides) as new anticancer agents.
Antonini I; Polucci P; Magnano A; Sparapani S; Martelli S
J Med Chem; 2004 Oct; 47(21):5244-50. PubMed ID: 15456268
[TBL] [Abstract][Full Text] [Related]
10. Isoquino[4,5-bc]acridines: design, synthesis and evaluation of DNA binding, anti-tumor and DNA photo-damaging ability.
Yang P; Yang Q; Qian X; Tong L; Li X
J Photochem Photobiol B; 2006 Sep; 84(3):221-6. PubMed ID: 16714120
[TBL] [Abstract][Full Text] [Related]
11. Substitution at the F-ring N-imide of the indolocarbazole antitumor drug NB-506 increases the cytotoxicity, DNA binding, and topoisomerase I inhibition activities.
Bailly C; Qu X; Chaires JB; Colson P; Houssier C; Ohkubo M; Nishimura S; Yoshinari T
J Med Chem; 1999 Jul; 42(15):2927-35. PubMed ID: 10425102
[TBL] [Abstract][Full Text] [Related]
12. Novel tetra-acridine derivatives as dual inhibitors of topoisomerase II and the human proteasome.
Vispé S; Vandenberghe I; Robin M; Annereau JP; Créancier L; Pique V; Galy JP; Kruczynski A; Barret JM; Bailly C
Biochem Pharmacol; 2007 Jun; 73(12):1863-72. PubMed ID: 17391647
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological study of a new series of 4'-demethylepipodophyllotoxin derivatives.
Duca M; Guianvarc'h D; Meresse P; Bertounesque E; Dauzonne D; Kraus-Berthier L; Thirot S; Léonce S; Pierré A; Pfeiffer B; Renard P; Arimondo PB; Monneret C
J Med Chem; 2005 Jan; 48(2):593-603. PubMed ID: 15658872
[TBL] [Abstract][Full Text] [Related]
14. Bisintercalating threading diacridines: relationships between DNA binding, cytotoxicity, and cell cycle arrest.
Wakelin LP; Bu X; Eleftheriou A; Parmar A; Hayek C; Stewart BW
J Med Chem; 2003 Dec; 46(26):5790-802. PubMed ID: 14667232
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antitumor properties of N-[2-(dimethylamino)ethyl]carboxamide derivatives of fused tetracyclic quinolines and quinoxalines: a new class of putative topoisomerase inhibitors.
Deady LW; Kaye AJ; Finlay GJ; Baguley BC; Denny WA
J Med Chem; 1997 Jun; 40(13):2040-6. PubMed ID: 9207945
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antitumor activity of 4-aminomethylthioxanthenone and 5-aminomethylbenzothiopyranoindazole derivatives.
Perni RB; Wentland MP; Huang JI; Powles RG; Aldous S; Klingbeil KM; Peverly AD; Robinson RG; Corbett TH; Jones JL; Mattes KC; Rake JB; Coughlin SA
J Med Chem; 1998 Sep; 41(19):3645-54. PubMed ID: 9733489
[TBL] [Abstract][Full Text] [Related]
17. 2,3-Dihydro-1H,7H-pyrimido[5,6,1-de]acridine-1,3,7-trione derivatives, a class of cytotoxic agents active on multidrug-resistant cell lines: synthesis, biological evaluation, and structure-activity relationships.
Antonini I; Polucci P; Kelland LR; Menta E; Pescalli N; Martelli S
J Med Chem; 1999 Jul; 42(14):2535-41. PubMed ID: 10411474
[TBL] [Abstract][Full Text] [Related]
18. Novel synthetic 2-amino-10-(3,5-dimethoxy)benzyl-9(10H)-acridinone derivatives as potent DNA-binding antiproliferative agents.
Gao C; Liu F; Luan X; Tan C; Liu H; Xie Y; Jin Y; Jiang Y
Bioorg Med Chem; 2010 Nov; 18(21):7507-14. PubMed ID: 20863710
[TBL] [Abstract][Full Text] [Related]
19. Influence of polyamine architecture on the transport and topoisomerase II inhibitory properties of polyamine DNA-intercalator conjugates.
Wang L; Price HL; Juusola J; Kline M; Phanstiel O
J Med Chem; 2001 Oct; 44(22):3682-91. PubMed ID: 11606133
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of modified quinolones as antitumoral acridones.
Tabarrini O; Cecchetti V; Fravolini A; Nocentini G; Barzi A; Sabatini S; Miao H; Sissi C
J Med Chem; 1999 Jun; 42(12):2136-44. PubMed ID: 10377219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]